Abstract:Objective: To study the role of miR-124 in myocardial ischemia-reperfusion induced cardiomyocyte injury by targeted regulation of beclin 1 (BECN 1). Method: The rat model of myocardial ischemia-reperfusion was established. The rats were divided into the miR-124 group (injected with miR-124 inhibitor), the MIRI group (not treated), and the miR-NC group (injected with miR-NC). Meanwhile, blank group and sham operation groups were set up. LDH and CK in the five groups were detected by ELISA at 12 h after operation. The myocardial infarct size of each group was measured by multimedia color pathological analysis. Then, an in vitro cell model was established. First, the rat cardiomyocytes were isolated, extracted and cultured; then miR-124 was transfected into the cells, the test group cells were transfected with miR-124, and the miR-NC were transfected into cells. NC cells were set as negative control group, and cells not transfected were set as blank control group. Then, an in vitro cell model was established. First, the rat cardiomyocytes were isolated, extracted and cultured, then cells transfected with miR-124 and miR-NC were set as test group and negative control group, and cells not transfected were set as blank control group. The relative expression of miR-124 in rat myocardium as well as in cardiomyocytes transfected with miR-124 were measured. Western blot was applied to analyze the relative expression levels of Beclin-1 and LC3B proteins in cardiomyocytes and flow cytometry was used to analyze the apoptosis of cells. Results: There were no significant differences in serum CK and LDH levels between the blank group, the sham operation group and the miR-124 group after modeling (P>0.05), but those of the MIRI group and the miR-NC group were significantly higher than that in the blank group, the sham operation group and the miR-124 group (P<0.05). The miR-124 in the myocardial tissue of the blank group, the sham operation group and the miR-124 group were significantly lower than those of the MIRI group and the miR-NC group (P<0.05). There was no significant difference in Beclin 1 mRNA expression among the five groups (P>0.05). The myocardial infarct size of the miR-124 group was significantly smaller than that of the MIRI group and the miR-NC groups (P<0.05). For in vitro results, the expression of miR-124 after transfection in the myocardial cells of the test group was significantly higher than that in the blank group and the negative control group (P<0.05). The expression levels of Bclin 1 and LC3 autophagy in the cardiomyocytes of the test group were significantly lower than those of the blank and negative control groups (P<0.05). The apoptosis rate of cardiomyocytes in the test group was also significantly higher than that in the blank group and the negative control group (P<0.05). Conclusion: miR-124 is highly expressed in MIRI and may reduce the level of autophagy and promote apoptosis through competitive binding of BECN 1, which may be an important target for MIRI treatment in the future.

miR-124-3p downregulates EGR1 to suppress ischemia-hypoxia reperfusion injury in human iPS cell-derived cardiomyocytes

MiR-129-5p Protects Against Myocardial Ischemia-Reperfusion Injury Via Targeting HMGB1

Retracted: MicroRNA‐132 Protects H9c2 Cells Against Oxygen and Glucose Deprivation‐evoked Injury by Targeting FOXO3A

Long Noncoding RNA AK123483 is Involved in the Regulation of Myocardial Ischaemia-Reperfusion Injury by Targeting PARP and Caspase-3

MiR-27a-3p Suppresses Cerebral Ischemia-Reperfusion Injury by Targeting FOXO1.

MicroRNA-124a Protects the Myocardium Against Ischemia Reperfusion Injury Through Regulation of the Notch Signaling Pathway

Exosomes/microvesicles from Induced Pluripotent Stem Cells Deliver Cardioprotective Mirnas and Prevent Cardiomyocyte Apoptosis in the Ischemic Myocardium

Mir-124 Regulates Myocardial Ischemia Reperfusion Injury

Abstract 17048: Exosomes from Induced Pluripotent Stem Cells Deliver Cardioprotective Mirnas and Prevent Cardiomyocyte Apoptosis in the Ischemic Myocardium

Downregulation Of Mir-34a Attenuates Myocardial Ischemia/Reperfusion Injury By Inhibiting Cardiomyocyte Apoptosis

miR‑124 inhibits cardiomyocyte apoptosis in myocardial ischaemia‑reperfusion injury by activating mitochondrial calcium uniporter regulator 1

MiR-137-3p exacerbates the ischemia-reperfusion injured cardiomyocyte apoptosis by targeting KLF15

MiR-138-5p exacerbates hypoxia/reperfusion-induced heart injury through the inactivation of SIRT1-PGC-1α

MicroRNA-15a Inhibition Protects Against Hypoxia/reoxygenation-Induced Apoptosis of Cardiomyocytes by Targeting Mothers Against Decapentaplegic Homolog 7

miR-124-3p targeted SIRT1 to regulate cell apoptosis, inflammatory response, and oxidative stress in acute myocardial infarction in rats via modulation of the FGF21/CREB/PGC1α pathway

Irisin protects cardiomyocytes against hypoxia/reoxygenation injury via attenuating AMPK mediated endoplasmic reticulum stress

miR-451-3p alleviates myocardial ischemia/reperfusion injury by inhibiting MAP1LC3B-mediated autophagy

Upregulation of Microrna-34A Enhances Myocardial Ischemia-Reperfusion Injury Via the Mitochondrial Apoptotic Pathway

MicroRNA-494 suppresses hypoxia/reoxygenation-induced cardiomyocyte apoptosis and autophagy via the PI3K/AKT/mTOR signaling pathway by targeting SIRT1

Overexpression of microRNA-378 attenuates ischemia-induced apoptosis by inhibiting caspase-3 expression in cardiac myocytes

Inhibition of miR-1224 suppresses hypoxia/reoxygenation-induced oxidative stress and apoptosis in cardiomyocytes through targeting GPX4